EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Cost-effectiveness of daily home haemodialysis versus in-centre haemodialysis: A propensity score matching analysis based on real-world data from the French healthcare system

Guy Rostoker, Jean-Jacques Dumas, Benoît Thomé, Victor-Alexandre Aragno, Michel Thomas, Bernard Canaud

European Journal of Internal Medicine · 2025-07 · 137 · 73-82

DOI: 10.1016/j.ejim.2025.04.017 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Internal Medicine, 2025-07. Verfasst von Guy Rostoker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Dialysis, Ramsay Health Care, Claude Galien Hospital, 20 route de Boussy, Quincy-sous-Sénart, 91480, France; Collège de Mé…. Hauptthemen laut MEDLINE: Hemodialysis, Home, Kidney Failure, Chronic, Renal Dialysis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ramsay Health Care, Ramsay Santé SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Daily home haemodialysis (HD) offers several advantages over conventional 3-times-weekly in-centre HD, with better preservation of quality of life and treatment flexibility, but its costs and potential benefits on mortality are poorly understood.

Methods

Individual healthcare data from the French National Health Data System for patients with end-stage kidney disease undergoing dialysis cross-referenced with the French National Cost Scale of the health ministry. After exclusion of patients treated < 90 days, and those without a treatment schedule or incomplete data for a social disadvantage score, 42 605 patients were selected (28 317 prevalent and 14 288 incident HD patients). After propensity score matching, 265 incident patients (in-centre HD, n = 212; daily home HD, n = 53) and 765 prevalent patients (in-centre HD, n = 612; daily home HD, n = 153) were analysed.

Findings

The global cost of daily home HD in incident patients was lower than in-centre HD (€1403/week vs. €1652/week, respectively). In prevalent patients, the cost was also slightly lower for daily home haemodialysis than compared to in-centre haemodialysis (€1360/week vs. €1456/week, respectively). The gross death rate in incident patients treated by in-centre HD after a 2-year follow-up was 10·4 % vs. 1·9 % for patients treated by daily home HD (p = 0·049, at Chi2 test; relative risk=5·5). Using a Cox proportional hazard regression model, in-centre HD was associated with a 7-fold higher risk of death (hazard ratio=7·888, p = 0·045).

Interpretation

Daily home HD is a more cost-effective and patient-centred treatment option than in-centre HD. Funding This research was funded by Physidia Ltd and Ramsay Health Care, France.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemodialysis, HomeKidney Failure, ChronicRenal DialysisHumansFranceFemaleMalePropensity ScoreAgedCost-Benefit AnalysisMiddle AgedQuality of Life

Stichwörter der Autor:innen

Daily home haemodialysisIn-centre haemodialysisIncident patientsMedico-economicsPrevalent patientsSurvival analysis

Autor:innen und Institutionen

  • Division of Nephrology and Dialysis, Ramsay Health Care, Claude Galien Hospital, 20 route de Boussy, Quincy-sous-Sénart, 91480, France; Collège de Médecine des Hôpitaux de Paris, 10 rue des Fossés Saint-Marcel, Paris 75…
  • AP-EX, 31, rue de la Fontaine Méchy, Sanry-lès-Vigy 57640, France.
  • Median Conseil, 2 avenue du Président Pierre Angot, Pau, 64000, France.
  • Medical Affairs, Physidia, 11-13 boulevard des Bretonnières, Saint-Barthélemy-d'Anjou 49124, France.
  • Emeritus Professor of Nephrology, University of Montpellier, 163 rue Auguste Broussonnet, Montpellier, 34090, France; AIDER Santé, Charles Mion Foundation, 191 avenue du Doyen Gaston Giraud, Montpellier, 34090, France.

Förderung

  • Ramsay Health Care
  • Ramsay Santé SA

Zitieren

APA

Rostoker, G., Dumas, J. J., Thomé, B., Aragno, V. A., Thomas, M., & Canaud, B. (2025). Cost-effectiveness of daily home haemodialysis versus in-centre haemodialysis: A propensity score matching analysis based on real-world data from the French healthcare system. European Journal of Internal Medicine, 137, 73-82. https://doi.org/10.1016/j.ejim.2025.04.017

Vancouver

Rostoker G, Dumas JJ, Thomé B, Aragno VA, Thomas M, Canaud B. Cost-effectiveness of daily home haemodialysis versus in-centre haemodialysis: A propensity score matching analysis based on real-world data from the French healthcare system. European Journal of Internal Medicine. 2025;137:73-82. doi:10.1016/j.ejim.2025.04.017

BibTeX
@article{Rostoker2025,
  author = {Rostoker, Guy and Dumas, Jean-Jacques and Thomé, Benoît and Aragno, Victor-Alexandre and Thomas, Michel and Canaud, Bernard},
  title = {Cost-effectiveness of daily home haemodialysis versus in-centre haemodialysis: A propensity score matching analysis based on real-world data from the French healthcare system},
  journal = {European Journal of Internal Medicine},
  year = {2025},
  volume = {137},
  pages = {73--82},
  doi = {10.1016/j.ejim.2025.04.017}
}
Kostenlos starten →